ICU sedation, delirium & recovery
Impact of High-Dose Early Mobilization on Outcomes for Patients with Diabetes: A Secondary Analysis of the TEAM Trial
Authors' conclusion
In this secondary analysis of the TEAM trial, in patients with diabetes, a high-dose early mobilization strategy did not significantly decrease the number of days alive and out of the hospital at Day 180, but it increased 180-day mortality.
Study context
- Population
- ICU patients of the TEAM trial
- Participants
- 741 patients
- Comparison
- High-dose early mobilization by diabetes status
- Diabetesn = 159
- Primary endpoint
- Days alive and out of hospital
- Follow-up
- Day 180
Methodological detailssubgroup analysis by diabetes status
- Subgroup analysis by diabetes status
Primary result
As reported in the abstract
Days alive and out of hospital with high-dose early mobilization
Secondary outcomes
Days alive and out of hospital, overall by diabetes status · Day 180
P = 0.013
Mortality, overall by diabetes status · 180 days
P = 0.044
Mortality with high-dose early mobilization (diabetes subgroup) · 180 days
| aOR (95% CI) | ||
|---|---|---|
| High-dose early mobilizationPatients with diabetes | 3.47 (1.67–7.61) | |
| 0.10.31310Adjusted odds ratio (log scale) |
- Mortality with high-dose early mobilization (diabetes subgroup): P value for interaction = 0.001
Original publication
Impact of High-Dose Early Mobilization on Outcomes for Patients with Diabetes: A Secondary Analysis of the TEAM Trial. Am J Respir Crit Care Med. Published 15 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →